Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fluorescein Sodium
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Carl Zeiss Meditec
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Alcon (Fluorescein Sodium) is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Brain Neoplasms.
Product Name : Alcon
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 22, 2020
Lead Product(s) : Fluorescein Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Carl Zeiss Meditec
Deal Size : Inapplicable
Deal Type : Inapplicable